Viatris (VTRS) Short term Debt (2019 - 2026)
Viatris (VTRS) posted quarterly Short term Debt of $1.9 billion for Q1 2026, up 15.1% year-over-year from $1.7 billion in Q1 2025, and little changed quarter-over-quarter from $1.9 billion in Q4 2025.
Viatris (VTRS) Short term Debt (2019 - 2026) Analysis & Trends
Viatris' Short term Debt history runs 8 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- In Q1 2026, Short term Debt rose 15.1% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $1.9 billion (up 15.1% YoY), while the FY2025 annual figure was $1.9 billion, up 322116.67% from the prior year.
- Short term Debt for Q1 2026 stood at $1.9 billion, roughly flat from $1.9 billion in the prior quarter.
- The five-year high for Short term Debt was $2.0 billion in Q3 2025, with the low at $100000.0 in Q3 2023.
- The 5-year median for Short term Debt is $1.7 billion (2024), against an average of $1.2 billion.
- The sharpest annual moves came in 2023 and 2024: Short term Debt sank 99.99% in 2023, then surged 1673800.0% in 2024.
- Viatris' Short term Debt stood at $1.3 billion in 2022, then surged by 53.66% to $1.9 billion in 2023, then plunged by 99.97% to $600000.0 in 2024, then surged by 322116.67% to $1.9 billion in 2025, then slipped by 0.29% to $1.9 billion in 2026.
- Business Quant data shows VTRS's Short term Debt at $1.9 billion in Q1 2026, $1.9 billion in Q4 2025, and $2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Bn |
| Mar 31, 2026 | 1.93 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 23.20 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 755.00 Mn |
| Jun 30, 2022 | 768.20 Mn |
| Mar 31, 2022 | 655.40 Mn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | 1.88 Bn |